FR2946884B1 - Composition de nacre pour une utilisation dans le traitement des lesions nerveuses, substrat neurogene comprenant ladite composition et leur procede de preparation - Google Patents

Composition de nacre pour une utilisation dans le traitement des lesions nerveuses, substrat neurogene comprenant ladite composition et leur procede de preparation

Info

Publication number
FR2946884B1
FR2946884B1 FR0954084A FR0954084A FR2946884B1 FR 2946884 B1 FR2946884 B1 FR 2946884B1 FR 0954084 A FR0954084 A FR 0954084A FR 0954084 A FR0954084 A FR 0954084A FR 2946884 B1 FR2946884 B1 FR 2946884B1
Authority
FR
France
Prior art keywords
composition
neurogen
preparing
substrate
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0954084A
Other languages
English (en)
Other versions
FR2946884A1 (fr
Inventor
Joel Drai
Serge Camprasse
Georges Camprasse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEGA BIO PHARMA, FR
Original Assignee
MEGA BIO PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEGA BIO PHARMA filed Critical MEGA BIO PHARMA
Priority to FR0954084A priority Critical patent/FR2946884B1/fr
Priority to PCT/FR2010/051202 priority patent/WO2010146309A1/fr
Publication of FR2946884A1 publication Critical patent/FR2946884A1/fr
Application granted granted Critical
Publication of FR2946884B1 publication Critical patent/FR2946884B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0954084A 2009-06-17 2009-06-17 Composition de nacre pour une utilisation dans le traitement des lesions nerveuses, substrat neurogene comprenant ladite composition et leur procede de preparation Active FR2946884B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0954084A FR2946884B1 (fr) 2009-06-17 2009-06-17 Composition de nacre pour une utilisation dans le traitement des lesions nerveuses, substrat neurogene comprenant ladite composition et leur procede de preparation
PCT/FR2010/051202 WO2010146309A1 (fr) 2009-06-17 2010-06-16 Composition de nacre pour une utilisation dans le traitement des lésions nerveuses, substrat neurogène comprenant ladite composition et leur procédé de préparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0954084A FR2946884B1 (fr) 2009-06-17 2009-06-17 Composition de nacre pour une utilisation dans le traitement des lesions nerveuses, substrat neurogene comprenant ladite composition et leur procede de preparation

Publications (2)

Publication Number Publication Date
FR2946884A1 FR2946884A1 (fr) 2010-12-24
FR2946884B1 true FR2946884B1 (fr) 2013-01-18

Family

ID=41360307

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0954084A Active FR2946884B1 (fr) 2009-06-17 2009-06-17 Composition de nacre pour une utilisation dans le traitement des lesions nerveuses, substrat neurogene comprenant ladite composition et leur procede de preparation

Country Status (2)

Country Link
FR (1) FR2946884B1 (fr)
WO (1) WO2010146309A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR954066A (fr) 1947-09-26 1949-12-19 Perfectionnements aux machines à fabriquer les chenilles à âme torsadée
FR2719478B1 (fr) * 1994-05-09 1996-07-26 Serge Camprasse Produit de régénération et de cicatrisation cutanée. Son procédé de fabrication ses applications.
FR2777190B1 (fr) 1998-04-14 2001-07-27 Georges Camprasse Procede d'extraction, identification des principes actifs contenus dans la coquille interne et externe des mollusques marins, leur utilisation dans des preparations a visee thera peutique,diagnostic et cosmetique
FR2827478B1 (fr) * 2001-07-18 2003-10-24 Jean Louis Montero Procede de preparation d'une poudre a base de nacre, proteine isolee de ladite poudre et leurs utilisations en chirurgie osseuse et dans diverses pathologies osteoarticulaires

Also Published As

Publication number Publication date
FR2946884A1 (fr) 2010-12-24
WO2010146309A1 (fr) 2010-12-23

Similar Documents

Publication Publication Date Title
FR2942963B1 (fr) Composition cosmetique comprenant une matiere colorante, ladite matiere colorante et procede de traitement cosmetique
CL2007000806A1 (es) Compuestos derivados de heteropentaciclos sustituidos; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento del cancer.
FR2932478B1 (fr) Composes utiles pour le traitement des cancers.
PL1975226T3 (pl) Płynna kompozycja do obróbki
CL2011000838A1 (es) Compuestos heterociclicos derivados de tetraciclos ortocondensados con un grupo pirimidina 2,4,6-triona espirocondensado, inhibidores de la adn girasa bacteriana; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una infeccion bacteriana.
HK1148284A1 (en) Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions hif
ZA200907215B (en) Uses of oligomers of lactic acid in the treatment of gynaecological disorders
PH12015501955B1 (en) Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
FR2934129B1 (fr) Procede de traitement cosmetique.
IL195152A (en) Compounds for use in treating diseases of cell culture
IL212707A0 (en) Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
CL2013001591A1 (es) Compuestos derivados de triazolopiridina; inhibidores de pde10a; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento o profilaxis de trastornos psicoticos, esquizofrenia, ansiedad, entre otras enfermedades.
FR2934267B1 (fr) Derives aminophosphiniques utiles dans le traitement de la douleur
CL2008000982A1 (es) Compuestos derivados de 5-oxo-isoxazol-carboxamida; proceso de preparacion; composicion farmaceutica; procedimiento de produccion de la composicion farmaceutica; y uso en el tratamiento y/o prevencion de trastornos ateroscleroticos, de metabolismo de
FR2933609B1 (fr) Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson.
CL2014001323A1 (es) Compuestos derivados de 3-fenil-isoquinolin-1(2h)-ona, inhibidores de parp-1; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer.
DE602006018505D1 (de) Photostabile pharmazeutische zusammensetzung mit brivudin zur behandlung von herpetischer keratitis
FR2957225B1 (fr) Procede d'elevage de coquillages, notamment des huitres.
FR2983733B1 (fr) Phytoecdysones pour leur utilisation dans l'amelioration de la qualite musculaire de mammiferes obeses et/ou sarcopeniques
FR2946884B1 (fr) Composition de nacre pour une utilisation dans le traitement des lesions nerveuses, substrat neurogene comprenant ladite composition et leur procede de preparation
ZA201103134B (en) (pyrrolidin-2 yl) phenyl derivatives for use in the treatment of pain
FR2973376B1 (fr) Derives utiles dans le traitement ou la prevention de tumeurs osseuses
FR2950058B1 (fr) Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
FR2930727B1 (fr) Composition pour le traitement des etats seborrheiques.
FR2954141B1 (fr) Procede pour capter des actifs dans la peau

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

TP Transmission of property

Owner name: MEGA BIO PHARMA, FR

Effective date: 20170227

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16